Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Neurocrine Biosciences Inc.
Headquarters:
San Diego, CA, United States
Website:
http://www.neurocrine.com
Year Founded:
1992
Status:
Public
Industry Sector:
HealthTechnology
CEO:
Kyle W. Gano, PhD, MBA
Number Of Employees:
1,800
Enterprise Value:
$13,574,650,000
PE Ratio:
40.88
Exchange/Ticker 1:
NASDAQ:NBIX
Exchange/Ticker 2:
N/A
Latest Market Cap:
$11,931,316,224